TP53 and cancer: Various oncogenic phenotypes and mechanisms of action, transcriptional and non-transcriptional, have been described for mutant p53 (Bellazzo et al., 2018; Kim and Lozano, 2018); nonetheless, our understanding of the real impact of mutp53 in cancer formation and progression remains incomplete.